BOT 0.00% 38.0¢ botanix pharmaceuticals ltd

Ann: FDA Mid-Cycle Review Meeting Successfully Completed, page-31

  1. 2,466 Posts.
    lightbulb Created with Sketch. 3442
    Don’t get too excited, we usually go down the tubes on positive news. But maybe this time it’s a little different. Market at some point needs to respectfully run up the share price.

    Would have been nice for management to hold off from a trading halt to bust a CR. I hope that it is a premium and not one of those VWAP 15% discount which will only force the market to tank the share price.
 
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.